+1 212 479 6840 ielrifi@cooley.com
Dr. Ivor Elrifi is the chair of Cooley's global patent counseling and prosecution practice group. He advises pharmaceutical, biotechnology, life sciences and medical device companies, research institutions, universities, hospitals and governments throughout the world, particularly in the US and Europe. His practice includes patent prosecution, litigation, arbitration, licensing and transactional work with a focus on novel therapeutic treatments, biotechnology, genetics, diagnostics, biomarkers, drug formulations and medical devices.
Download full bio
Syros – $58 Million IPO
AveXis – $95 Million IPO
WAVE Life Sciences - $102 Million IPO
Voyager Therapeutics - $80.5 Million IPO
Catabasis Completes $69 Million IPO
View all
Intellectual Property
Patent Counseling & Prosecution – Life Sciences
Patent Office Litigation
Life Sciences IP Litigation
Life Sciences
Medtech
Israel
Patent Strategy & Management Attorney of the Year
Osgoode Hall Law SchoolJD, 1989
Queen's UniversityPhD, Biology, 1986
Queen's UniversityBS, Biology1982
California
Massachusetts
New York
Ontario Canada Bar
United States Patent & Trademark Office
Legal 500 US 2019 Highlights Cooley August 29, 2019
Therachon Agrees to Sell to Pfizer for Up to $810 Million May 21, 2019
Chambers USA 2019 Recognizes Cooley Lawyers + Practices April 30, 2019
LMG Life Sciences: Patent Strategy & Management Attorney of the Year (2018)
LMG Life Sciences: Life Sciences Star
Euromoney: Global Leader in Patent Law
Managing Intellectual Property: IP Star
IAM Patent 1000: Leading Patent Lawyer
Chambers and Legal 500: Leading Patent and Life Sciences Lawyer
Super Lawyers: Top IP Lawyer
+1 212 479 6840 office +1 212 479 6275 fax ielrifi@cooley.com
55 Hudson YardsNew York, NY 10001-2157
Other Offices